Moreover, experiments with Apo-E deficient mice proved that fenofibrate could also act in a lipid/glucose metabolism independent manner, since the infarct size was still reduced by the PPARα agonist after these mice developed hyperglycemia (Deplanque et al., 2003). The gene discussed is PPARA; the disease is Hyperglycemia.